## GL: Globe Life Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -0.5% below STRENGTH zone (3.0-6.0%); PEG 1.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($128.31)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Bronstein, Gewirtz & Grossman, LLC Encourages Globe Life Inc. (GL) Stockholders to Inquire about Securities Investigation**
- Source: MyChamplainValley.com | 20251209T160808 | Neutral | Relevance: 98%
-  Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. (NYSE:GL) securities who bought prior to May 8, 2019, and still hold their shares. The investigation aims to determine if Globe Life and its officers/directors engaged in corporate wrongdoing. Investors are encouraged to contact the firm for more information or to assist with the investigation.

**2. Analysts See a 28% Potential Upside in Globe Life Inc. (GL)**
- Source: Insider Monkey | 20251208T185800 | Bullish | Relevance: 98%
-  Analysts project a 28% potential upside for Globe Life Inc. (NYSE:GL), with a consensus 1-year median price target of $168.50. Despite Morgan Stanley reducing its price objective, it maintains an "Overweight" rating for GL. The company reported increased premium revenue, projecting significant growth in agents and annual sales by 2030, and expects robust net operating earnings per diluted share for 2025.

**3. Natixis Purchases 123,396 Shares of Globe Life Inc. $GL**
- Source: MarketBeat | 20251209T124529 | Somewhat-Bullish | Relevance: 98%
-  Natixis significantly increased its holdings in Globe Life Inc. (NYSE:GL) by 348.3% in the second quarter, acquiring an additional 123,396 shares to bring its total to 158,823 shares worth $19.74 million. Other institutional investors also adjusted their positions in the company. Globe Life's stock opened at $133.04, with institutional investors and hedge funds owning 81.61% of the stock.

**4. Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Globe Life Inc. (GL) and Encourages Investors to Learn More About the Investigation**
- Source: KLAS 8 News Now | 20251207T160818 | Neutral | Relevance: 97%
-  Bronstein, Gewirtz & Grossman, LLC has announced an investigation into potential corporate wrongdoing by Globe Life Inc. (NYSE: GL) and its officers/directors. The firm is encouraging investors who purchased Globe Life securities before May 8, 2019, and still hold them, to come forward and assist in their investigation. The investigation aims to determine if there were any misconducts by the company.

**5. 9 Best Life Insurance Stocks to Buy Now**
- Source: Insider Monkey | 20251207T180855 | Somewhat-Bullish | Relevance: 73%
-  Principal Financial Group, Inc. (NASDAQ:PFG) is highlighted as one of the best life insurance stocks, currently held by 34 hedge funds. The company offers attractive long-term dividend growth potential with 16 years of dividend growth and expects 9-12% annual non-GAAP EPS growth. Morgan Stanley recently increased its price objective for Principal Financial Group to $87, maintaining an Underweight rating.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Morgan Stanley | $177 | $179 | -1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.24M) |
| Sells | 1 ($5.38M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.7%)
- Blackrock Inc.: 7.2% (-2.1%)
- Invesco Ltd.: 4.8% (-1.9%)
- State Street Corpora: 4.1% (-3.5%)
- Wellington Managemen: 3.5% (-29.0%)

### Key Risks

1. Insider selling cluster: $5.4M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Forward P/E 8.9x stretched relative to 3% growth. Quality metrics strong (ROE 22%, margin 19%). Balance sheet: strong liquidity (2.8x). Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($5.4M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $10.8B |
| Beta | 0.48 |
| 52W Range | $100.62 - $147.83 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 8.9 |
| Current P/E | 9.1 |
| YoY Growth | 2.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -3.5% to -0.5% (+3.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.5pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.8%) - potential reversal signal. RSI neutral at 50.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.54% (CS: 53) | Neutral |
| RSI_14 | 50.5 | Neutral |
| MACD Histogram | 0.15 | Bullish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 0.992x | Below |
| vs SMA200 | 1.027x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $133.09
- **Stop Loss:** $128.31 (3.6% risk)
- **Target:** $137.87 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 104
- **Position Value:** $13,841.36
- **Portfolio %:** 13.84%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-04 (Est: $3.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.54 | $4.81 | +5.9% |
| 2025Q2 | $3.25 | $3.27 | +0.8% |
| 2025Q1 | $3.24 | $3.07 | -5.2% |
| 2024Q4 | $3.12 | $3.14 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*